View Archive »
About The Cover
The cover for issue 39 of Oncotarget features Figure 3, "The Integrated Behavior Change model linking perceived autonomy support, autonomous motivation, attitudes, subjective norms, perceived behavioral control, intention and planning on Physical Activity behavior," by Galli, et al.
|
|
Table of Contents
Editorial: Autophagy and Cell Death
|
| Autophagy inhibition improves anticancer drugs via FOXO3a activation |
|
https://doi.org/10.18632/oncotarget.25366
|
| 25384-25385 |
Priority Research Papers
|
| Melanomaassociated mutants within the serinerich domain of PAK5 direct kinase activity to mitogenic pathways |
|
https://doi.org/10.18632/oncotarget.25356
|
| 25386-25401 |
Gerotarget/Focus on Aging
|
| Active lifestyles in older adults: an integrated predictive model of physical activity and exercise |
|
https://doi.org/10.18632/oncotarget.25352
|
| 25402-25413 |
Research Papers
|
| miR513a5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonuclease |
|
https://doi.org/10.18632/oncotarget.11003
|
| 25414-25426 |
|
| Transcriptional activation of p21Waf1 contributes to suppression of HR by p53 in response to replication arrest induced by camptothecin |
|
https://doi.org/10.18632/oncotarget.25172
|
| 25427-25440 |
|
| Engineering of a rough auxotrophic mutant Salmonella Typhimurium for effective delivery |
|
https://doi.org/10.18632/oncotarget.25192
|
| 25441-25457 |
|
| STK3 is a therapeutic target for a subset of acute myeloid leukemias |
|
https://doi.org/10.18632/oncotarget.25238
|
| 25458-25473 |
|
| Evaluation of appropriate followup after curative surgery for patients with colorectal cancer using time to recurrence and survival after recurrence: a retrospective multicenter study |
|
https://doi.org/10.18632/oncotarget.25312
|
| 25474-25490 |
|
| Associations of blood mitochondrial DNA copy number with socialdemographics and cancer risk: results from the ManoAMano Mexican American Cohort |
|
https://doi.org/10.18632/oncotarget.25321
|
| 25491-25502 |
|
| NEDD9 stimulated MMP9 secretion is required for invadopodia formation in oral squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25347
|
| 25503-25516 |
|
| Computational development of a molecularbased approach to improve risk stratification of endometrial cancer patients |
|
https://doi.org/10.18632/oncotarget.25354
|
| 25517-25528 |
|
| Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death |
|
https://doi.org/10.18632/oncotarget.25368
|
| 25529-25544 |
|
| Bcl2 inhibition sensitizes triplenegative human breast cancer cells to doxorubicin |
|
https://doi.org/10.18632/oncotarget.25370
|
| 25545-25556 |
|
| Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members obese and nonobese controls – a preliminary report |
|
https://doi.org/10.18632/oncotarget.25374
|
| 25557-25571 |
|
| Diminished gallbladder filling increased fecal bile acids and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15deficient mice |
|
https://doi.org/10.18632/oncotarget.25385
|
| 25572-25585 |
|
| Concurrent but not sequential PD1 blockade with a DNA vaccine elicits antitumor responses in patients with metastatic castrationresistant prostate cancer |
|
https://doi.org/10.18632/oncotarget.25387
|
| 25586-25596 |
|
| From mono to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFRexpressing tumor cells in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.25390
|
| 25597-25616 |
|
| Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma |
|
https://doi.org/10.18632/oncotarget.25424
|
| 25617-25629 |
|
| Combined HAT/EZH2 modulation leads to cancerselective cell death |
|
https://doi.org/10.18632/oncotarget.25428
|
| 25630-25646 |
|
| Multiomics profiling reveals a distinctive epigenome signature for highrisk acute promyelocytic leukemia |
|
https://doi.org/10.18632/oncotarget.25429
|
| 25647-25660 |
|
| Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins |
|
https://doi.org/10.18632/oncotarget.25432
|
| 25661-25680 |
|
| Metaanalysis of homocysteinerelated factors on the risk of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25355
|
| 25681-25697 |
|
| Dietary cholesterol intake and stroke risk: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.23933
|
| 25698-25707 |
Clinical Research Papers
|
| Risk factors for hemoglobinuria after ultrasonographyguided percutaneous microwave ablation for large hepatic cavernous hemangiomas |
|
https://doi.org/10.18632/oncotarget.25379
|
| 25708-25713 |
|
| Lean body mass wasting and toxicity in early breast cancer patients receiving anthracyclines |
|
https://doi.org/10.18632/oncotarget.25394
|
| 25714-25722 |
|
| Thyroid function in the etiology of fatigue in breast cancer |
|
https://doi.org/10.18632/oncotarget.25438
|
| 25723-25737 |
Reviews
|
| Anticancer drugsrelated QTc prolongation torsade de pointes and sudden death: current evidence and future research perspectives |
|
https://doi.org/10.18632/oncotarget.25008
|
| 25738-25749 |
Corrections
|
| Correction: Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloidβ in APP/PS1 mice |
|
https://doi.org/10.18632/oncotarget.22813
|
| 25750-25750 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
